Is Neutrophil Lymphocyte Ratio an Indicator for Proteinuria in Chronic Kidney Disease?

Overview

Journal J Clin Lab Anal

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
Pathology

Date 2014 Mar 25

PMID 24659410

Citations 11

Authors

Emine Binnetoglu

Erkan Sengul

Gokcen Halhalli

Sevim Dindar

Hacer Sen

Affiliations

Soon will be listed here.

Abstract

Background: Recent studies have shown that neutrophil lymphocyte ratio (NLR) is a strong indicator in determining inflammation in cardiac and non-cardiac diseases. We aimed to evaluate the relationship between proteinuria and NLR in chronic kidney disease (CKD) patients without diabetes mellitus (DM).

Methods: Between 2011 and 2012 files of a total of 1000 CKD patients attending outpatient clinic were retrospectively scanned. Patients with DM, chronic disease, malignancy or stage 5 CKD were excluded. After these patients were excluded, a total of 69 patients with stage 3 and 4 CKD were evaluated.

Results: The study comprised 27 patients with CKD without proteinuria (Group 1), 42 patients with CKD and proteinuria (Group 2) and 30 healthy volunteers (Group 3). NLR was highest in Group 2 and this was statistically significant compared with the control group (p = 0.012). The platelet lymphocyte ratio (PLR) in Group 2 was higher than the control group at a significant level (p = 0.004). There was a moderate positive correlation found between proteinuria and NLR (p = 0.013, r = 0.3). There was a positive correlation found between proteinuria and PLR (p = 0.002, r = 0.306).

Conclusion: In conclusion, NLR, a parameter easily found in routine blood counts of CKD patients, is a marker with prognostic value for the presence and degree of proteinuria.

Citing Articles

Evaluation of peripheral blood inflammatory biomarkers in sickle cell disease with and without retinopathy.

Ozer O, Dogan L, Baysal Z, Basir H, Ciftci A, Eroz P Graefes Arch Clin Exp Ophthalmol. 2024; 262(12):3787-3796.

PMID: 38976013 PMC: 11608169. DOI: 10.1007/s00417-024-06569-9.

The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study.

Pang L, Ding Z, Chai H, Shuang W Open Med (Wars). 2023; 18(1):20230877.

PMID: 38152332 PMC: 10751893. DOI: 10.1515/med-2023-0877.

Clinical significance of neutrophil-to-lymphocyte ratio on the risk of abdominal aortic calcification and decreased bone mineral density in patients with end-stage kidney disease.

Ban T, Choi B, Yoon S, Kim Y, Jin K, Kim G PLoS One. 2023; 18(10):e0286612.

PMID: 37878613 PMC: 10599515. DOI: 10.1371/journal.pone.0286612.

Increased risk of chronic kidney disease in uric acid stone formers with high neutrophil-to-lymphocyte ratio.

Tung H, Liu C, Huang H, Lu Z, Liu C Sci Rep. 2023; 13(1):17686.

PMID: 37848540 PMC: 10582096. DOI: 10.1038/s41598-023-45034-1.

A Retrospective Analysis of the Association of Neutrophil-Lymphocyte Ratio (NLR) with Anemia in the Saudi Population.

Alshuweishi Y, Alfaifi M, Almoghrabi Y, Al-Sheikh Y, Alfhili M Medicina (Kaunas). 2023; 59(9).

PMID: 37763711 PMC: 10536447. DOI: 10.3390/medicina59091592.

References

Huang Z, Chen Y, Wu K, Chen M . Higher peripheral neutrophil and monocyte counts are independent indicators of the presence and severity of proteinuria in apparently normal adults. Intern Med J. 2010; 40(1):30-6. DOI: 10.1111/j.1445-5994.2008.01881.x. View

Turkmen K, Erdur F, Ozcicek F, Ozcicek A, Akbas E, Ozbicer A . Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013; 17(3):391-6. DOI: 10.1111/hdi.12040. View

Cravedi P, Remuzzi G . Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013; 76(4):516-23. PMC: 3791975. DOI: 10.1111/bcp.12104. View

van den Berg J, Weening J . Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond). 2004; 107(2):125-36. DOI: 10.1042/CS20040095. View

Tonelli M, Muntner P, Lloyd A, Manns B, Klarenbach S, Pannu N . Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844):807-14. DOI: 10.1016/S0140-6736(12)60572-8. View

van Kooten C, Gerritsma J, Paape M, van Es L, Banchereau J, Daha M . Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int. 1997; 51(3):711-21. DOI: 10.1038/ki.1997.102. View

Agrawal V, Marinescu V, Agarwal M, McCullough P . Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol. 2009; 6(4):301-11. DOI: 10.1038/nrcardio.2009.11. View

Muhlhauser I, Verhasselt R, Sawicki P, Berger M . Leucocyte count, proteinuria and smoking in type 1 diabetes mellitus. Acta Diabetol. 1993; 30(2):105-7. DOI: 10.1007/BF00578223. View

Afsar B . The relationship between neutrophil lymphocyte ratio with urinary protein and albumin excretion in newly diagnosed patients with type 2 diabetes. Am J Med Sci. 2013; 347(3):217-20. DOI: 10.1097/MAJ.0b013e31828365cc. View

10.

Remuzzi G, Bertani T . Pathophysiology of progressive nephropathies. N Engl J Med. 1998; 339(20):1448-56. DOI: 10.1056/NEJM199811123392007. View

11.

Cravedi P, Ruggenenti P, Remuzzi G . Kidney failure stabilizes after an increase over 2 decades. J Ren Care. 2009; 33(3):100-4. DOI: 10.1111/j.1755-6686.2007.tb00052.x. View

12.

Moreno-Manzano V, Mampaso F, Sepulveda-Munoz J, Alique M, Chen S, Ziyadeh F . Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol. 2003; 139(4):823-31. PMC: 1573906. DOI: 10.1038/sj.bjp.0705311. View

13.

DAmico G, Ferrario F, Rastaldi M . Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis. 1995; 26(1):124-32. DOI: 10.1016/0272-6386(95)90165-5. View

14.

Tsai J, Sheu S, Chiu H, Chung F, Chang D, Chen M . Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2006; 23(2):111-8. DOI: 10.1002/dmrr.647. View